Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Articles

Induction of Interleukin 2 Production but not Methionine Adenosyltransferase Activity or S-Adenosylmethionine Turnover in Jurkat T-Cells

James De La Rosa, Arthur M. Geller, H. Leighton LeGros Jr. and Malak Kotb
James De La Rosa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arthur M. Geller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Leighton LeGros
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malak Kotb
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published June 1992
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

We have recently reported that methionine adenosyltransferase (MAT) in resting human peripheral blood T-cells is primarily present in the form of a precursor which we named λ. This protein decreases upon cell stimulation, as both MAT activity and the amount of the catalytic α/α′ subunits of the enzyme increase. When resting cells are activated by phytohemagglutinin, the decrease in λ and increase in α/α′ occurs after interleukin 2 (IL-2) production and before DNA synthesis. The human T-leukemia cell line, Jurkat, is unique in its ability to produce IL-2 in response to exogenous stimuli such as T-cell mitogens and therefore provides a convenient model for studying biochemical reactions involved in T-cell activation. In this study the regulation of MAT activity and S-adenosylmethionine (AdoMet) in resting and activated Jurkat cells was investigated. Here we report that MAT activity in unstimulated Jurkat cells is about 10- and 3-fold higher than the activity in resting and activated peripheral blood mononuclear cells, respectively. Activation of Jurkat cells with phytohemagglutinin resulted in increased IL-2 production, but not an increase in MAT activity. Identical results were obtained using freshly isolated cells from acute lymphoblastic leukemia patients. AdoMet utilization and pool size were approximately 3- and 10-fold higher, respectively, in Jurkat cells compared to peripheral blood mononuclear cells, and both parameters were unaffected by phytohemagglutinin stimulation. Jurkat MAT was determined to be structurally indistinguishable from enzyme from T- or B-leukemia cells but was different from resting, normal T-cells in that it lacked the λ form. Furthermore, unlike MAT in resting T-cells, the relative amounts of the α, α′, and β subunits of the enzyme did not change throughout the course of IL-2 induction. We conclude that AdoMet metabolism and MAT activity in Jurkat cells are constitutively high and that induction of IL-2 synthesis in these cells is independent of changes in AdoMet synthesis or turnover. The lack of the λ form and the difference in MAT regulation between leukemic T-cells and peripheral blood mononuclear cells may be exploited in the design of specific chemotherapeutic agents.

Footnotes

  • ↵1 This work was supported in part by grants from the United States Veterans Administration (M. K.), and from the NIH, GM-38530 (M. K.). The ALL-2 cells were obtained from The Leukemia Cell Bank (LCB) at St. Jude's Children's Research Hospital with the assistance of Dr. Fredrick Behm. The LCB is supported by the National Cancer Institute and by funds from the American Lebanese and Syrian Associated Charities.

  • ↵2 To whom requests for reprints should be addressed, at the V. A. Medical Center (151), 1030 Jefferson Ave., Memphis, TN 38104.

  • Received November 20, 1991.
  • Accepted April 7, 1992.
  • ©1992 American Association for Cancer Research.
PreviousNext
Back to top
June 1992
Volume 52, Issue 12
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Induction of Interleukin 2 Production but not Methionine Adenosyltransferase Activity or S-Adenosylmethionine Turnover in Jurkat T-Cells
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Induction of Interleukin 2 Production but not Methionine Adenosyltransferase Activity or S-Adenosylmethionine Turnover in Jurkat T-Cells
James De La Rosa, Arthur M. Geller, H. Leighton LeGros Jr. and Malak Kotb
Cancer Res June 15 1992 (52) (12) 3361-3366;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Induction of Interleukin 2 Production but not Methionine Adenosyltransferase Activity or S-Adenosylmethionine Turnover in Jurkat T-Cells
James De La Rosa, Arthur M. Geller, H. Leighton LeGros Jr. and Malak Kotb
Cancer Res June 15 1992 (52) (12) 3361-3366;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Insights from Bcl-2 and Myc: Malignancy Involves Abrogation of Apoptosis as well as Sustained Proliferation
  • Core-Binding Factor: A Central Player in Hematopoiesis and Leukemia
  • Introduction of Stanley J. Korsmeyer
Show more Articles
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement